Drug Pricing

Blog

Newsom’s ‘Bold’ Plan on Prescription Drugs Won’t Really Help Patients, Lower Drug Costs

In a state where the private sector continues to be marginalized in favor of more government, Gov. Gavin Newsom has plans for California to set up a generic drug label of its own. It would be the first state in the country to go into the pharmaceutical business, and will ...
Commentary

Price Controls Impose High Costs On Patients

Twenty-five years ago, the leading cause of death for adults between the ages of 25 and 44 was complications from HIV. At the time, 50,000 Americans were dying from AIDS-related causes a year, with the African American community particularly hard hit – 49 percent of the people dying from AIDS-related deaths ...
Drug Pricing

Wayne Winegarden Drug Pricing Study Featured in Healthcare Finance News

Drug supply chain, pricing system reforms will slash healthcare costs, says PRI By Jeff Lagasse As the Trump administration pushes for price caps and government controls to address prescription drug prices, a new issue brief released by the Center for Medical Economics and Innovation at the Pacific Research Institute contends ...
Drug Pricing

Wayne Winegarden – Why the Pelosi and Newsom Approaches to Prescription Drugs Won’t Really Help Patients

Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, breaks down recently-proposed plans in Washington and Sacramento that emphasize price caps and more government control to address prescription drug prices. He discusses the conclusions of his new study on America’s drug pricing challenge, which makes the case ...
Blog

Taxpayers Exhausted from Newsom’s Marathon Budget Presser

Gov. Newsom’s announcement of his 2020-21 State Budget plan on Friday was another whopper, his speech clocking in at roughly 2 hours and 47 minutes.  Last year, reporters who were used to covering a 30 minute press conference where caught off guard by Newsom’s lengthy presentation.  Los Angeles Times reporter ...
Blog

Lies, Damn Lies, and Drug Price Increases

As each new year begins, the increases in the list prices of drugs are announced. And, following these announcements, the political class complains that something must be done. This year, following the price announcements, Speaker Nancy Pelosi tweeted “Enough is enough” while Senator Grassley emphasized that a “call to action” ...
Drug Pricing

NEW STUDY shows that Reforming Supply Chain & Drug Pricing System Will Lower Health Care Costs

As Washington pushes for price caps and government controls to address prescription drug prices, a new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute argues that reforming the complex drug supply chain and ending the current drug pricing system that overcharges ...
Commentary

Democrats’ health care mistakes of 2019 – five things they keep getting wrong

Whether on the debate stage or in the halls of Congress, over the past year Democrats have misled the public on just about every major health care issue. As 2019 draws to a close, let’s look at the five biggest things Democrats got wrong on health care this year. Supporters of “Medicare-for-all” routinely ...
Commentary

To Help Patients, Reform The Drug Pricing System Don’t Impose Price Controls

Yesterday the House passed the ill-considered “Pelosi bill” that would impose draconian price controls on drugs. Ignoring the bill’s many adverse impacts, price control advocates like Speaker Pelosi appear to believe that these command and control schemes can solve the systemic health care affordability problem. But, as the latest government data illustrates, ...
Commentary

USMCA Will Help American Patients

President Trump has often said that he wants to lower drug prices, in part by ending foreign “freeloading.” That’s a laudable goal. Through price controls and other ham-handed policies, too many nations undervalue medical innovation. This leaves Americans with the majority of the world’s research burden. Unfortunately, in an attempt ...
Blog

Newsom’s ‘Bold’ Plan on Prescription Drugs Won’t Really Help Patients, Lower Drug Costs

In a state where the private sector continues to be marginalized in favor of more government, Gov. Gavin Newsom has plans for California to set up a generic drug label of its own. It would be the first state in the country to go into the pharmaceutical business, and will ...
Commentary

Price Controls Impose High Costs On Patients

Twenty-five years ago, the leading cause of death for adults between the ages of 25 and 44 was complications from HIV. At the time, 50,000 Americans were dying from AIDS-related causes a year, with the African American community particularly hard hit – 49 percent of the people dying from AIDS-related deaths ...
Drug Pricing

Wayne Winegarden Drug Pricing Study Featured in Healthcare Finance News

Drug supply chain, pricing system reforms will slash healthcare costs, says PRI By Jeff Lagasse As the Trump administration pushes for price caps and government controls to address prescription drug prices, a new issue brief released by the Center for Medical Economics and Innovation at the Pacific Research Institute contends ...
Drug Pricing

Wayne Winegarden – Why the Pelosi and Newsom Approaches to Prescription Drugs Won’t Really Help Patients

Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics and Innovation, breaks down recently-proposed plans in Washington and Sacramento that emphasize price caps and more government control to address prescription drug prices. He discusses the conclusions of his new study on America’s drug pricing challenge, which makes the case ...
Blog

Taxpayers Exhausted from Newsom’s Marathon Budget Presser

Gov. Newsom’s announcement of his 2020-21 State Budget plan on Friday was another whopper, his speech clocking in at roughly 2 hours and 47 minutes.  Last year, reporters who were used to covering a 30 minute press conference where caught off guard by Newsom’s lengthy presentation.  Los Angeles Times reporter ...
Blog

Lies, Damn Lies, and Drug Price Increases

As each new year begins, the increases in the list prices of drugs are announced. And, following these announcements, the political class complains that something must be done. This year, following the price announcements, Speaker Nancy Pelosi tweeted “Enough is enough” while Senator Grassley emphasized that a “call to action” ...
Drug Pricing

NEW STUDY shows that Reforming Supply Chain & Drug Pricing System Will Lower Health Care Costs

As Washington pushes for price caps and government controls to address prescription drug prices, a new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute argues that reforming the complex drug supply chain and ending the current drug pricing system that overcharges ...
Commentary

Democrats’ health care mistakes of 2019 – five things they keep getting wrong

Whether on the debate stage or in the halls of Congress, over the past year Democrats have misled the public on just about every major health care issue. As 2019 draws to a close, let’s look at the five biggest things Democrats got wrong on health care this year. Supporters of “Medicare-for-all” routinely ...
Commentary

To Help Patients, Reform The Drug Pricing System Don’t Impose Price Controls

Yesterday the House passed the ill-considered “Pelosi bill” that would impose draconian price controls on drugs. Ignoring the bill’s many adverse impacts, price control advocates like Speaker Pelosi appear to believe that these command and control schemes can solve the systemic health care affordability problem. But, as the latest government data illustrates, ...
Commentary

USMCA Will Help American Patients

President Trump has often said that he wants to lower drug prices, in part by ending foreign “freeloading.” That’s a laudable goal. Through price controls and other ham-handed policies, too many nations undervalue medical innovation. This leaves Americans with the majority of the world’s research burden. Unfortunately, in an attempt ...
Scroll to Top